ADAPALENE AND BENZOYL PEROXIDE Drug Patent Profile
✉ Email this page to a colleague
When do Adapalene And Benzoyl Peroxide patents expire, and when can generic versions of Adapalene And Benzoyl Peroxide launch?
Adapalene And Benzoyl Peroxide is a drug marketed by Actavis Mid Atlantic, Encube, Glenmark Pharms Ltd, Padagis Israel, and Taro. and is included in six NDAs.
The generic ingredient in ADAPALENE AND BENZOYL PEROXIDE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adapalene And Benzoyl Peroxide
A generic version of ADAPALENE AND BENZOYL PEROXIDE was approved as adapalene; benzoyl peroxide by ACTAVIS MID ATLANTIC on September 30th, 2015.
Summary for ADAPALENE AND BENZOYL PEROXIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 5 |
| Clinical Trials: | 40 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in ADAPALENE AND BENZOYL PEROXIDE? | ADAPALENE AND BENZOYL PEROXIDE excipients list |
| DailyMed Link: | ADAPALENE AND BENZOYL PEROXIDE at DailyMed |
Recent Clinical Trials for ADAPALENE AND BENZOYL PEROXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mahidol University | Phase 2 |
| Beiersdorf | Phase 2 |
| Vichy Laboratoires | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ADAPALENE AND BENZOYL PEROXIDE
US Patents and Regulatory Information for ADAPALENE AND BENZOYL PEROXIDE
ADAPALENE AND BENZOYL PEROXIDE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting ADAPALENE AND BENZOYL PEROXIDE
PATENT CHALLENGE
Exclusivity Expiration: See Plans and Pricing
